Yan, Y <br/><br/>
Irradiation-induced G2/M checkpoint response requires ERK1/2 activation.  [electronic resource] 

 -  Oncogene  Jul 2007 
 - 4689-98 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1210268  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ataxia Telangiectasia Mutated Proteins<br/>CDC2 Protein Kinase--metabolism<br/>Cell Cycle Proteins--antagonists & inhibitors<br/>Cell Division--radiation effects<br/>Cell Line, Tumor<br/>Checkpoint Kinase 1<br/>DNA Damage<br/>DNA Repair<br/>DNA-Binding Proteins--antagonists & inhibitors<br/>G2 Phase--radiation effects<br/>Humans<br/>Mitogen-Activated Protein Kinase 1--antagonists & inhibitors<br/>Mitogen-Activated Protein Kinase 3--antagonists & inhibitors<br/>Nuclear Proteins--metabolism<br/>Phosphorylation<br/>Protein Kinases--metabolism<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Protein-Tyrosine Kinases--metabolism<br/>RNA, Small Interfering--pharmacology<br/>Tumor Suppressor Proteins--antagonists & inhibitors<br/>cdc25 Phosphatases--metabolism